Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Locoregional Radionuclide Cancer Therapy -

Locoregional Radionuclide Cancer Therapy

Clinical and Scientific Aspects

Franklin C.L. Wong (Herausgeber)

Buch | Softcover
XII, 268 Seiten
2021 | 1st ed. 2021
Springer International Publishing (Verlag)
978-3-030-56269-4 (ISBN)
CHF 149,75 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

This book reviews locoregional radionuclide cancer therapies (LRCT). Proving an increasingly viable alternative to radiotherapy, radionuclide therapy includes a diversity of choices of well characterized biochemical and physiologic target molecules. The delivery and retention of radionuclides may be monitored by advanced imaging for exact tissue localization and for real-time dosimetry to enable personalized precision medicine. Radiopharmaceuticals in human cancer therapies are typically delivered in systemic routes but can also be designed for locoregional routes to harness pharmacokinetic advantages of higher payload and lower systemic toxicities. This book explores the latest advancements and clinical considerations of the locoregional approach.

Throughout the chapters, the clinical and scientific bases of cancer treatment and the locoregional use of radionculides are explored. Mathematical models of radiation dosimetry of locoregional radionculdies on tissues are studied using common models for multiple commercially available radionuclides. Rodent and canine tumor models of LRCT are compared for selected radionuclides and radiopharmaceuticals. The practical aspects of radiopharmaceuticals production, marketing, transport, as well as radiation protection are reviewed. Finally, the combination of LRCT with immunotherapy and other cancer therapies and prospective future use of LRCT are discussed.

This is a guide for practicing nuclear physicians, interventional radiologists, radiation oncologists, radiation scientists, veterinarians and oncologists to expand their knowledge base and to prepare for designing locoregional radionuclide cancer therapies in animals and in humans.


lt;p>

Franklin C. L. Wong

University of Texas

MD Anderson Cancer Center

Houston, TX

USA


Human Cancer- Epidemiology, Hallmarks, and Defense Strategies.- Cancer Treatment Modalities Systemic and Loco regional Approaches: Challenges and Opportunities of multidisciplinary approaches.- Cancer Radiotherapy: General Considerations and Human Radiobiology.- Radionuclide Cancer Therapy- Unsealed Alpha, Beta and Gamma Emitters.- Locoregional Therapy - Cancer Interventions with and without Radionuclides.- Radiation Dosimetry Considerations of Locoregional Radionuclide Cancer Therapy.- Voxel-based Targeted Radionuclide Therapy Dosimetry.- Locoregional Unsealed Radionuclide Cancer Therapy - Experimental Findings.- Animal Cancer Therapy Models - Ready Translation to Humans.- An Overview of Regulations of Radiopharmaceuticals.- Locoregional Radionuclide Cancer Therapy (LRCT) Using Sealed & Unsealed Radionuclides.


Erscheinungsdatum
Zusatzinfo XII, 268 p. 76 illus., 56 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 530 g
Themenwelt Medizinische Fachgebiete Radiologie / Bildgebende Verfahren Nuklearmedizin
Schlagworte Cancer Therapy • Imaging algorithms • Leptomeningeal metastasis • Locoregional • locoregional radionuclide cancer therapies • LRCT • Radionuclide Therapy
ISBN-10 3-030-56269-7 / 3030562697
ISBN-13 978-3-030-56269-4 / 9783030562694
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
Basiswissen und klinische Anwendung

von Markus Dietlein; Klaus Kopka; Matthias Schmidt …

Buch (2023)
Thieme (Verlag)
CHF 199,95
Lehrbuch für Breast Care Nurses und Fachpersonen in der Onkologie

von Manuela Eicher; Sara Marquard; Monika Biedermann …

Buch | Hardcover (2020)
Hogrefe (Verlag)
CHF 63,00